✦ LIBER ✦

Rituximab long-term maintenance therapy after autologous stem cell transplantation in patients with B-cell non-Hodgkin’s lymphoma

✍ Scribed by Frank Neumann; Stefani Harmsen; Simona Martin; Ralf Kronenwett; Mustafa Kondakci; Manuel Aivado; Ulrich Germing; Rainer Haas; Guido Kobbe

Publisher: Springer
Year: 2006
Tongue: English
Weight: 96 KB
Volume: 85
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-006-0113-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab therapy increased post-transpl

Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin’s lymphoma patients receiving autologous hematopoietic stem cell transplantation

✍ Ming-Yang Lee; Tzeon-Jye Chiou; Liang-Tsai Hsiao; Muh-Hwa Yang; Pang-Chan Lin; S 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 111 KB

Post-autologous stem cell transplantatio

Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin’s lymphoma

✍ Panagiotis Tsirigotis; Liliane Dray; Igor B. Resnick; Aliza Ackerstein; Benjamin 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 187 KB

Allogeneic stem cell transplantation in

Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation

✍ Ji-Won Kim; Byung-Su Kim; Soo-Mee Bang; Inho Kim; Dong Hwan Kim; Won Seog Kim; D 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 197 KB

Therapeutic results in patients with rel

Therapeutic results in patients with relapsed diffuse large B cell Non-Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation

✍ Felicetto Ferrara; Assunta Viola; Carolina Copia; Ettore Mariano Schiavone; Mari 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract Forty patients with relapsed diffuse large B cell lymphoma (DLBCL) autografted in partial response (PR) (__n__ = 23) or in refractory relapse (RR) (__n__ = 17) achieved complete remission (CR) after autologous stem cell transplantation (ASCT). Salvage treatment consisted of ifosphamide,

A long-lasting third complete remission

A long-lasting third complete remission after second autologous transplant followed by maintenance treatment with rituximab in a patient with diffuse large cell non-Hodgkin's lymphoma

✍ Selmin Ataergin; Fikret Arpaci; Murat Beyzadeoglu; Mukerrem Safali; Ahmet Ozet 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 1 views

Chemotherapy with rituximab followed by

Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma

✍ Catherine Thieblemont; Daciana Antal; Laurence Lacotte-Thierry; Vincent Delwail; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

## Abstract ## BACKGROUND The authors evaluated the efficacy of chemotherapy combined with rituximab followed by high‐dose therapy (HDT) plus autologous stem cell transplantation in patients with mantle cell lymphoma (MCL). ## METHODS This was a retrospective analysis of 34 patients who were tre